# Ileus

Manage suspected ileus by first excluding mechanical obstruction, ischemia, perforation, and acute colonic pseudo-obstruction. Correct reversible drivers, decompress selectively for vomiting or marked distention, minimize opioids, mobilize early, and escalate predominant colonic dilation to monitored neostigmine or endoscopic decompression.

**Clinical question:** How should clinicians distinguish ileus from obstruction and pseudo-obstruction, stabilize patients, and select decompression or escalation?

Updated: 2026-09-16T01:04:57.391776+00:00

## What matters in practice
- Do not label postoperative distention as ileus until mechanical obstruction, bowel ischemia, and perforation have been considered; persistent or worsening obstruction requires surgical assessment rather than prolonged expectant management. [17]
- Predominant colonic dilation without mechanical obstruction suggests acute colonic pseudo-obstruction; small-bowel dilation accompanying colonic dilation favors postoperative ileus. [5]
- Initial treatment of functional obstruction is bowel rest when clinically indicated, isotonic IV fluid and electrolyte correction, removal of motility-inhibiting drugs, opioid minimization, and selective nasogastric decompression for emesis or gastric distention. [17][21][23]
- In acute colonic pseudo-obstruction refractory to conservative management, IV neostigmine 2 mg can produce colonic decompression but requires continuous cardiac monitoring because bradycardia, heart block, and serious arrhythmias may occur. [20][22]
- A colon diameter greater than 10 cm is associated with perforation risk in pseudo-obstruction and should prompt decompression planning rather than continued observation alone. [24]

## Identify obstruction, ischemia, or perforation before treating presumed ileus

Functional obstruction is a diagnosis reached after excluding a structural or surgical cause.

Treat hemodynamic instability, peritonitis, suspected perforation, or concern for strangulation/ischemia as an urgent surgical problem. Begin isotonic IV fluid resuscitation and correct electrolyte abnormalities; use nasogastric decompression for clinically important vomiting, gastric distention, or aspiration risk. Mechanical small-bowel obstruction with strangulation, ischemia, or failure to resolve requires operative management. [17]

In an adult with postoperative or acute inpatient distention, obtain abdominal imaging to define the distribution of bowel dilation and assess for a mechanical transition point or other obstructing lesion. Multiple dilated, fluid-filled bowel loops can represent either paralytic ileus or mechanical small-bowel obstruction, so radiographic dilation alone does not establish functional disease. [13]

Do not use passage of stool or flatus as reassurance when abdominal distention is progressing. A reported pseudo-obstruction case developed marked enlargement despite regular bowel movements and flatus after conservative treatment; serial examination and repeat assessment of abdominal girth or colonic diameter should drive escalation. [23]
- Immediately assess volume status, vomiting/aspiration risk, abdominal tenderness or peritoneal signs, medication exposures, recent operation or trauma, severe systemic illness, and electrolyte or metabolic derangements. [17][23]
- Use lactated Ringer solution or normal saline for intravascular depletion associated with third spacing, emesis, or reduced oral intake; correct hypokalemia and other electrolyte abnormalities concurrently. [17]
- With bilious vomiting in an infant, presume bowel obstruction until proved otherwise and obtain urgent pediatric surgical review; this is not a setting for a presumptive diagnosis of ileus. [15][16]

*Initial pattern recognition for functional versus mechanical bowel obstruction. [5][13][17]*

| Clinical-radiographic pattern | Interpretation | Immediate next action |
| --- | --- | --- |
| Diffuse bowel dilation with air-fluid levels | Compatible with paralytic ileus but may overlap with mechanical small-bowel obstruction. [13] | Assess for a mechanical cause; resuscitate, correct electrolytes, and decompress selectively for vomiting or gastric distention. [17] |
| Colonic dilation without mechanical obstruction | Acute colonic pseudo-obstruction is likely. [12] | Remove precipitating factors, monitor colonic diameter, and plan decompression if conservative management fails or dilation is high risk. [20][24] |
| Colonic dilation plus small-bowel dilation after surgery | Pattern used to classify postoperative ileus rather than isolated colonic pseudo-obstruction. [5] | Treat reversible contributors and reassess if symptoms or distention worsen. [17][23] |
| Mechanical obstruction with ischemia, strangulation, or lack of resolution | Structural obstruction requiring definitive management. [17] | Urgent surgical management. [17] |

## Separate postoperative ileus from acute colonic pseudo-obstruction

The distribution of dilation changes the treatment pathway.

Postoperative ileus is commonly driven by recent surgical inflammation and opioid analgesia; it occurs in up to 50% of patients after abdominal surgery. Initial management is directed at removing the precipitant, particularly replacing opioid analgesia with nonopioid options where feasible, while encouraging ambulation and using nasogastric decompression if worsening emesis or distention develops. [24]

Acute colonic pseudo-obstruction (Ogilvie syndrome) is colonic dysmotility with colonic distention in the absence of mechanical obstruction. It occurs after surgery or trauma in approximately 50% to 60% of reported cases and is associated with older age, immobility or neurologic impairment, opioid exposure, infection, metabolic disorders, extensive surgery, and medications that inhibit intestinal motility. [5][9][24]

Measure and trend the maximal colonic diameter when acute colonic pseudo-obstruction is suspected. A colon greater than 10 cm is described as at risk for perforation, with the cecum particularly vulnerable because it has the largest radius; this threshold should trigger active decompression planning after exclusion of mechanical obstruction. [24]
- Favor postoperative ileus when both small bowel and colon are dilated after surgery. [5]
- Favor acute colonic pseudo-obstruction when imaging shows predominant colonic dilation without an obstructing lesion. [5][12]
- Do not treat presumed pseudo-obstruction with neostigmine until a mechanical obstruction has been excluded. [12][22]

### Recurrent or refractory colonic dilation

For recurrent symptoms despite medical and endoscopic management of acute colonic pseudo-obstruction, reconsider whether the patient has an underlying colonic functional disorder, including slow-transit dysmotility or chronic intestinal pseudo-obstruction, rather than repeated isolated acute episodes. [12]

*Functional-obstruction phenotypes and management implications. [5][9][12][24]*

| Feature | Postoperative ileus | Acute colonic pseudo-obstruction |
| --- | --- | --- |
| Predominant dilation pattern | Small-bowel dilation with colonic dilation supports postoperative ileus. [5] | Colonic dilation without mechanical obstruction. [12] |
| Common setting | Recent abdominal surgery; inflammatory mediators and opioid analgesia contribute. [24] | Surgery, trauma, severe illness, metabolic disorders, motility-inhibiting medications, older age, and immobility. [5][9][24] |
| Initial intervention | Reduce or replace opioids, correct reversible abnormalities, mobilize, and consider nasogastric decompression for worsening emesis. [17][24] | Correct fluid, electrolyte, and metabolic triggers; stop opioids and anticholinergic agents; keep NPO during active distention and decompress if conservative care fails. [20][23] |
| Escalation pathway | Reevaluate for mechanical obstruction or other surgical pathology if symptoms progress or fail to resolve. [17] | For refractory disease, use monitored neostigmine or colonoscopic decompression; consider recurrence as a signal for chronic dysmotility. [12][20][22] |

## Correct reversible drivers and use selective decompression

Supportive treatment should target the mechanism maintaining dysmotility rather than simply delay intervention.

Place patients with clinically significant ileus or pseudo-obstruction on bowel rest while treating the precipitating condition. Replace fluid, electrolyte, and metabolic deficits, and discontinue or reduce medications that impair motility, especially opioids and anticholinergic agents. For postoperative ileus, changing pain treatment from opioid to nonopioid analgesia is an early intervention; for pseudo-obstruction, wean narcotics to the lowest dose that provides acceptable analgesia. [17][23][24]

Use nasogastric decompression selectively for gastric distention, persistent vomiting, or aspiration risk; it relieves distention and vomiting but does not correct the underlying dysmotility. In pseudo-obstruction conservative care, nasogastric suction, NPO status, IV fluids, electrolyte replacement, avoidance of offending medications, frequent repositioning, and ambulation are used while serially reassessing distention. [17][20][23]

For postoperative prevention and recovery, implement the relevant components of an enhanced-recovery pathway: minimally invasive surgery when feasible, optimized fluid management, opioid-sparing analgesia, early mobilization, early postoperative food intake when not contraindicated, laxatives, and omission or early removal of postoperative nasogastric intubation. The ERAS emergency-laparotomy guideline rates this multifaceted approach as a strong recommendation with moderate-quality evidence. [19]
- Review medication administration records for opioid and anticholinergic exposure; actively stop, reduce, or substitute these agents when clinically possible. [23][24]
- Track abdominal examination, emesis, nasogastric output when present, electrolyte replacement, and imaging-defined bowel or colon caliber rather than relying on a single bedside finding. [17][23]
- Reintroduce oral or enteral nutrition as gastrointestinal function recovers and contraindications resolve; if enteral feeding remains contraindicated, early parenteral nutrition may be indicated after emergency laparotomy. [19]

*Actionable supportive-management bundle for ileus and pseudo-obstruction. [17][19][23][24]*

| Action | When to use it | Operational target |
| --- | --- | --- |
| Isotonic IV fluid and electrolyte correction | Volume depletion, emesis, third spacing, hypokalemia, or other metabolic abnormalities. [17][23] | Restore intravascular volume and correct abnormalities that perpetuate dysmotility. [17][23] |
| Opioid reduction or substitution | Postoperative ileus or pseudo-obstruction with opioid exposure. [23][24] | Use nonopioid analgesia where feasible; otherwise reduce narcotics to the lowest effective dose. [23][24] |
| Nasogastric tube | Vomiting, gastric distention, or aspiration risk. [17] | Decompress the stomach while reassessing for a structural cause or need for escalation. [17][23] |
| Mobilization and repositioning | Hemodynamically stable postoperative patients and patients with functional obstruction. [19][23] | Support recovery of gut function and reduce postoperative ileus burden. [19] |
| Bowel rest, then nutrition reassessment | Active symptomatic ileus or pseudo-obstruction; resume intake when function recovers. [19][23] | Avoid enteral intake during unresolved functional obstruction; use parenteral nutrition when enteral feeding is contraindicated after emergency laparotomy. [19] |

## Use neostigmine or endoscopic decompression for refractory acute colonic pseudo-obstruction

Escalation applies to confirmed colonic pseudo-obstruction after conservative measures and exclusion of mechanical obstruction.

For acute colonic pseudo-obstruction refractory to conservative management, administer neostigmine 2 mg intravenously in a monitored setting. In a randomized placebo-controlled trial of 21 patients, IV neostigmine produced effective colonic decompression in refractory disease. [22]

Continuous cardiac monitoring is required during neostigmine administration because the drug can cause bradycardia, heart block, and life-threatening arrhythmias. These adverse effects are the principal operational limitation of pharmacologic decompression. [20]

Use colonoscopic decompression when decompression is needed and neostigmine is unsuitable, unavailable, or unsuccessful. Endoscopic decompression is an established specific therapy for acute colonic pseudo-obstruction; other described nonsurgical approaches include fluoroscopically guided decompression tubes and percutaneous cecostomy through endoscopic, laparoscopic, or surgical approaches. [9][23]

Escalate beyond medical or endoscopic management if perforation, peritonitis, or a mechanical process is identified. Do not redirect a patient with suspected ischemia, strangulation, or unresolved mechanical obstruction into an ileus pathway. [17]
- Before neostigmine: confirm a pseudo-obstructive colonic pattern and exclude mechanical obstruction. [12][22]
- During neostigmine: use continuous cardiac monitoring because of bradyarrhythmic risk. [20]
- After failure or recurrence: reassess colonic diameter, repeat the diagnostic review for structural disease, and consider chronic dysmotility in recurrent cases. [12][23]

*Escalation choices for acute colonic pseudo-obstruction. [9][12][20][22][23][24]*

| Clinical situation | Preferred escalation | Key limitation or monitoring |
| --- | --- | --- |
| Confirmed ACPO refractory to conservative management | Neostigmine 2 mg IV. [22] | Continuous cardiac monitoring for bradycardia, heart block, and potentially life-threatening arrhythmia. [20] |
| High-risk colonic dilation | Plan decompression when colon diameter exceeds 10 cm. [24] | Confirm absence of mechanical obstruction before pharmacologic decompression. [12][22] |
| Neostigmine unsuitable, unavailable, or unsuccessful | Colonoscopic decompression. [9][23] | Maintain correction of precipitating factors and monitor for recurrent distention. [23] |
| Peritonitis, perforation, ischemia, strangulation, or mechanical obstruction | Urgent surgical evaluation and definitive management. [17] | Do not manage as uncomplicated functional obstruction. [17] |

## Prevent postoperative ileus and monitor for diagnostic drift

Prevention is most effective when embedded in perioperative care rather than added after established distention.

For patients undergoing emergency laparotomy, use a bundled ileus-prevention strategy rather than a single intervention: minimally invasive approaches when feasible, optimized fluid administration, opioid-sparing analgesia, early mobilization, early postoperative feeding when clinically permissible, laxatives, and avoidance or early removal of a nasogastric tube. [19]

If a presumed postoperative ileus worsens after initial opioid reduction, ambulation, electrolyte correction, and selective gastric decompression, reopen the structural differential rather than repeatedly adding promotility agents. Worsening emesis, increasing distention, or failure to improve should trigger reassessment for mechanical obstruction and surgical complications. [17][24]

After bowel surgery or emergency laparotomy, advance oral or enteral nutrition when gastrointestinal function recovers and contraindications have ended. When enteral feeding cannot be used, early parenteral nutrition is recommended to mitigate inadequate intake, with transition back to oral or enteral feeding once caloric needs can be met safely. [19]
- Avoid routine prolonged postoperative nasogastric intubation; omit it or remove it early when clinically appropriate. [19]
- Use opioid-sparing analgesia as both an analgesic strategy and an ileus-prevention intervention. [19][24]
- Escalate recurrent pseudo-obstruction after medical or endoscopic therapy to evaluation for slow-transit dysmotility or chronic intestinal pseudo-obstruction. [12]

*Monitoring findings that should change the ileus management plan. [12][17][19][23][24]*

| Finding | Interpretation | Action |
| --- | --- | --- |
| Improving emesis and distention with recovering gastrointestinal function | Supports recovery of functional obstruction. [19] | Resume oral or enteral intake when safe; remove parenteral support once caloric needs are met enterally or orally. [19] |
| Increasing abdominal girth or persistent marked colonic dilation | May represent progressive acute colonic pseudo-obstruction despite stool or flatus. [23] | Trend colonic diameter and escalate to monitored neostigmine or endoscopic decompression when indicated. [20][22][24] |
| Colon diameter greater than 10 cm | Higher perforation risk in pseudo-obstruction. [24] | Arrange decompression rather than continued observation alone. [24] |
| Persistent or worsening symptoms after initial ileus treatment | Raises concern for mechanical obstruction or a surgical complication. [17] | Repeat diagnostic assessment and obtain urgent surgical input when ischemia, strangulation, or unresolved obstruction is suspected. [17] |

## References
1. [PDF] 203952Orig1s000 - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/203952Orig1s000MedR.pdf
2. [PDF] NDA Inter-Disciplinary Review and Evaluation - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/drugsatfda_docs/pediatric/419_203441%20S-013_teduglutide_Unireview%20prea.pdf
3. [PDF] Hyaluronic Acid (HA): Medical Device Material Safety Summary - FDA — www.fda.gov — https://www.fda.gov/media/158489/download
4. [PDF] 215019Orig1s000 INTEGRATED REVIEW - accessdata.fda.gov — www.accessdata.fda.gov — https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215019Orig1s000IntegratedR.pdf
5. Ogilvie Syndrome as a Postoperative Complication — jamanetwork.com — https://jamanetwork.com/journals/jamasurgery/fullarticle/390622
6. VA AT IO N — academic.oup.com — https://academic.oup.com/ajhp/article-pdf/14/6/619/28274291/ajhp0619.pdf
7. insights from the SPRING-SIR national Italian registry | Rheumatology — academic.oup.com — https://academic.oup.com/rheumatology/article/65/1/keaf457/8248581
8. Acute appendicitis causing small bowel obstruction - Oxford Academic — academic.oup.com — https://academic.oup.com/jscr/article/2025/10/rjaf809/8277756
9. Adynamic Ileus and Acute Colonic Pseudo-Obstruction - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0025712508000035
10. The acute contrast enema in suspected large bowel obstruction: Value and technique - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0009926005801709
11. Colonic pseudo-obstruction following termination of pregnancy and uterine operation - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/0002937876904567
12. Acute Colonic Pseudo-Obstruction - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/35966377
13. [PDF] Good clinical diagnostic practice — applications.emro.who.int — https://applications.emro.who.int/dsaf/dsa236.pdf
14. [PDF] ICD-11 Reference Guide - World Health Organization (WHO) — icdcdn.who.int — https://icdcdn.who.int/icd11referenceguide/en/refguide.pdf
15. [PDF] Hospital care for children - WHO | Regional Office for Africa — www.afro.who.int — https://www.afro.who.int/sites/default/files/2017-06/pocket_booklet_hospital_care_0.pdf
16. [PDF] Hospital care for children - IRIS — iris.who.int — https://iris.who.int/server/api/core/bitstreams/8f110da0-22e6-4ef1-90e4-c9f1b7daa363/content
17. Small Bowel Obstruction - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK448079
18. Diseases of the Alimentary Tract — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7167529
19. Consensus Guidelines for Perioperative Care for Emergency Laparotomy Enhanced Recovery After Surgery (ERAS®) Society Recommendations Part 2—Emergency Laparotomy: Intra- and Postoperative Care - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10241558
20. Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5604700
21. Prevention and Management of Postoperative Ileus: A Review of Current Practice - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8963477
22. Neostigmine for acute colonic pseudo–obstruction: New use for an old drug? - Gastroenterology — www.gastrojournal.org — https://www.gastrojournal.org/article/S0016-5085(00)70229-0/fulltext
23. Neostigmine to Relieve a Suspected Colonic Pseudo-Obstruction in a Burn Patient: A Case-Based Review of the Literature - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC3549582
24. Question Sets and Answers - PMC - NIH — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7120678

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.